KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Other Operating Expenses (2016 - 2025)

Cvs Health (CVS) has disclosed Other Operating Expenses for 16 consecutive years, with $103.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 8.64% year-over-year to $103.6 billion, compared with a TTM value of $397.4 billion through Dec 2025, up 9.09%, and an annual FY2025 reading of $397.4 billion, up 397507.0% over the prior year.
  • Other Operating Expenses was $103.6 billion for Q4 2025 at Cvs Health, down from $106.1 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $190.3 billion in Q4 2021 and bottomed at -$5.2 billion in Q3 2022.
  • Average Other Operating Expenses over 4 years is $68.9 billion, with a median of $89.7 billion recorded in 2024.
  • The sharpest move saw Other Operating Expenses soared 59.87% in 2021, then crashed 105.42% in 2022.
  • Year by year, Other Operating Expenses stood at $190.3 billion in 2021, then plummeted by 100.05% to -$99.0 million in 2022, then skyrocketed by 96405.05% to $95.3 billion in 2024, then grew by 8.64% to $103.6 billion in 2025.
  • Business Quant data shows Other Operating Expenses for CVS at $103.6 billion in Q4 2025, $106.1 billion in Q3 2025, and $96.5 billion in Q2 2025.